Product Images Sildenafil Citrate

This is a medication with sildenafil citrate USP, equivalent to 20 mg sildenafil per film-coated tablet. It should be stored at 20°C-25°C but can tolerate excursions to 15°C-30°C. It should be dispensed in tight containers and is only available through prescription. The medication is manufactured by Rubicon Research Private Limited and distributed by TruPharma, LLC. Patient information is available on the website www.trupharma.com. Keep out of reach of children.*

This is a description of sildenafil citrate tablets that contain 20mg of sildenafil. The tablets are film-coated and should be stored between 20°C-25°C (68°F-77°F) with permitted excursions up to 15°C-30°C (59°F-86°F). The tablets should be dispensed in tight containers and kept out of reach of children. The tablets are distributed by TruPharma, LLC and manufactured by Rubicon Research Private Limited in Maharashtra, India. The patient information sheet is available on the website www.trupharma.com.*

This text appears to be a chart presenting recommendations for adjusting drug doses based on the interaction fold change and 90% confidence interval. It includes information for specific drugs, their AUC, Cmax, and nodose adjustments. The chart also includes a reference to the change relative to Sildenafil alone and mentions exercise capacity benefits or lack thereof when adding skienafl to bosentan therapy.*

This is a drug interaction table that shows the effects of Acenocoumarol when taken with other drugs. The table indicates whether or not a dose adjustment is recommended based on the fold change and 90% confidence interval. There are also notes on the study of the effects of certain drugs on patient's exercise capacity.*

This is a table showing the change from baseline in meters for various weeks of a study involving different doses of sildenafil (20mg, 40mg, and 80mg) and a placebo. The table is not complete and doesn't provide any context or explanation for the study.*

This seems to be a medical research report related to idiopathic Pulmonary Arterial Hypertension (PAH) treatment. The report discusses the effectiveness of Sildenafil, a medication used for PAH, with dosage mentioned as 20 mg TID. The results show a placebo-corrected change in a 6-minute walk distance in meters by patients with PAH who were given Sildenafil. Apart from this, patient data is also mentioned, which includes age, gender, and medical history.*